Citation
Phase 3 Clinical Trial of Investigational Vaccine for COVID-19 Begins
TL;DR
Vaccine designed within 2 days of sequence publication
Documents the timeline of mRNA-1273 development: genetic sequence published January 11, 2020; vaccine designed within 2 days; first batch shipped February 24; Phase 1 trials began March 16, 2020; FDA Emergency Use Authorization December 18, 2020.
Illustrates how timing and random sampling during crisis bottlenecks can determine which organizations emerge with breakthrough capabilities fixed.
Key Findings from Moderna (2020)
- Vaccine designed within 2 days of sequence publication
- Phase 1 trials began 65 days after sequence published
- FDA EUA granted 11 months after pandemic began